← Back
Data updated: Mar 29, 2026
USV
Cardiovascular
Generics
USV is a generic drug manufacturer focused on Cardiovascular.
2014
Since
3
Drugs
-
Trials
22
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
ZOLEDRONIC ACID 2026-02-05
OLOPATADINE HYDROCHLORIDE 2026-01-06
ZOLEDRONIC ACID 2025-08-15
Labeling
ZOLEDRONIC ACID 2025-07-30
Labeling
OLOPATADINE HYDROCHLORIDE 2025-07-14
EPTIFIBATIDE 2025-06-13
Labeling
EPTIFIBATIDE 2025-03-25
Labeling
ZOLEDRONIC ACID 2025-03-13
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2014-09-04
- Latest
- 2023-05-19
- Applications
- 4